Followup to: Since the upward trendline broke - it now has become more of a support.
Possible Catalysts by End of January to assist this breakout: 1.) Update from NASDAQ meeting held this month (as to whether an extension to April will be given).
Possible Catalysts by March: 2.) Update regarding FDA Amendment that was sought after regarding Feb 2017 decision to discontinue trial. This news might take sometime depending on results / urgency.
Possible Catalysts anticipated by April to May: 3.) Preliminary results for ARGS-003 and ARGS-004 trials.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.